Emerging role of RAB GTPases in cancer and human disease.
暂无分享,去创建一个
G. Mills | John P. Lahad | J. Gray | K. Cheng
[1] Mike Rossner,et al. Show me the data , 2007, The Journal of cell biology.
[2] G. Mills,et al. The RAB25 small GTPase determines aggressiveness of ovarian and breast cancers , 2004, Nature Medicine.
[3] Wayne A. Phillips,et al. Mutation of the PIK3CA Gene in Ovarian and Breast Cancer , 2004, Cancer Research.
[4] W. Hahn,et al. A Genetically Defined Model for Human Ovarian Cancer , 2004, Cancer Research.
[5] D. Albertson. Profiling Breast Cancer by Array CGH , 2003, Breast Cancer Research and Treatment.
[6] A. Wandinger-Ness,et al. Rab proteins and endocytic trafficking: potential targets for therapeutic intervention. , 2003, Advanced drug delivery reviews.
[7] Trevor Hastie,et al. Gene expression patterns in ovarian carcinomas. , 2003, Molecular biology of the cell.
[8] A. Regev,et al. Molecular analysis of transitional cell carcinoma using cDNA microarray , 2003, Oncogene.
[9] C. Thompson,et al. Rab7 prevents growth factor-independent survival by inhibiting cell-autonomous nutrient transporter expression. , 2003, Developmental cell.
[10] W. Mobley,et al. NGF Signaling in Sensory Neurons Evidence that Early Endosomes Carry NGF Retrograde Signals , 2003, Neuron.
[11] R. Tibshirani,et al. Repeated observation of breast tumor subtypes in independent gene expression data sets , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[12] Wen-Lin Kuo,et al. Specific keynote: genome copy number abnormalities in ovarian cancer. , 2003, Gynecologic oncology.
[13] J. Zavadil,et al. Single cell behavior in metastatic primary mammary tumors correlated with gene expression patterns revealed by molecular profiling. , 2002, Cancer research.
[14] Cheryl Jorcyk,et al. Alterations in gene expression profiles during prostate cancer progression: functional correlations to tumorigenicity and down-regulation of selenoprotein-P in mouse and human tumors. , 2002, Cancer research.
[15] Yong-jie Lu,et al. Chromosome 1q expression profiling and relapse in Wilms' tumour , 2002, The Lancet.
[16] M. Odero,et al. Genomic imbalances detected by comparative genomic hybridization are prognostic markers in invasive ductal breast carcinomas , 2002, Histopathology.
[17] P. Courtoy,et al. The endocytic catalysts, Rab5a and Rab7, are tandem regulators of thyroid hormone production , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[18] G. Mills,et al. The role of genetic abnormalities of PTEN and the phosphatidylinositol 3-kinase pathway in breast and ovarian tumorigenesis, prognosis, and therapy. , 2001, Seminars in oncology.
[19] S. Korsmeyer,et al. Proapoptotic BAX and BAK: A Requisite Gateway to Mitochondrial Dysfunction and Death , 2001, Science.
[20] A. Fischer,et al. Mutations in RAB27A cause Griscelli syndrome associated with haemophagocytic syndrome , 2000, Nature Genetics.
[21] D. Hanahan,et al. The Hallmarks of Cancer , 2000, Cell.
[22] I. Nagata,et al. Gains of 1q21-q22 and 13q12-q14 are potential indicators for resistance to cisplatin-based chemotherapy in ovarian cancer patients. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.
[23] S. Korsmeyer,et al. BCL-2 family members and the mitochondria in apoptosis. , 1999, Genes & development.
[24] Joe W. Gray,et al. PIK3CA is implicated as an oncogene in ovarian cancer , 1999, Nature Genetics.
[25] W. Kuo,et al. High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays , 1998, Nature Genetics.
[26] I. Petersen,et al. Identification of allelic losses in benign, borderline, and invasive epithelial ovarian tumors and correlation with clinical outcome , 1997, Cancer.